FDA Inspection 1176624 — Xytex Laboratories
The FDA completed an inspection of Xytex Laboratories on Jul 26, 2022 in Charlotte, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 26, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Charlotte, NC (United States)